Charudutta Panigrahi | Will Odisha Pharma Summit 2025 Be a Defining Moment for Eastern India?

Odisha is all set to host the Odisha Pharma Summit 2025, a landmark event that could redefine the industrial trajectory of the state. Positioned as a gateway for Pharma and MedTech, the conclave is more than just a showcase, it is a statement of intent. With ambitious targets like 2.5 lakh jobs, large-scale investments and a roadmap to integrate Odisha into India’s pharmaceutical growth story, the state is stepping into the national stage with confidence.

India currently contributes around 20 percent of global generic drug exports and its domestic industry is worth over $50 billion. Odisha’s entry into this sector is both strategic and symbolic and is in line with the Prime Minister’s Purvodaya vision of industrial revival in eastern India. But the question is whether this summit will deliver concrete results or risk becoming another high-profile event with limited impact.

Learning from Other States

Odisha’s precedents are not unprecedented. Other states have successfully leveraged regional strengths to attract investment:

Telangana has transformed Hyderabad into the pharma capital of India by building dedicated pharma parks and providing regulatory ease.

Gujarat has invested heavily in logistics and testing infrastructure, making Ahmedabad a reliable hub for generic drugs.

Maharashtra has positioned Pune as a biotechnology and MedTech cluster supported by strong academic-industry linkages.

Tamil Nadu has shown how regional branding can boost investor confidence by promoting Coimbatore as a textile and engineering hub.

Odisha now aims to emulate these successes by tailoring the investment narrative to the strengths of its regions.

Odisha’s Regional Investment Story

Coastal Odisha: The coastal zone with ports such as Paradip and Dhamra is prepared for logistics, transportation and pharmaceutical production for export. Its proximity to global trade routes makes it ideal for bulk pharmaceutical exports and cold chain infrastructure.

Southern Odisha: Rich in biodiversity and tribal heritage, this region can be boosted for eco-friendly pharmaceutical research, herbal medicines and agro-based MedTech industries.

Northern Odisha: Mineral-rich regions such as Keonjhar and Mayurbhanj offer chemical intermediates and downstream manufacturing opportunities that complement pharmaceutical supply chains.

Central Odisha: Already a knowledge capital, Bhubaneswar can support R&D, IT-enabled pharmaceutical services and clinical trials supported by institutions like AIIMS and IIT Bhubaneswar.

Western Odisha: With its agricultural base, this region is ripe for pharmaceutical startups linked to food processing, nutraceuticals and renewable energy, driving inclusive growth.

By promoting the unique strengths of each region, Odisha can ensure balanced development across the state, offering investors a mosaic of opportunities.

Promise and Potential

The government has promised 2.5 lakh jobs. Assuming even just 10% materializes, this would mean 25,000 new jobs; a significant increase in a state where unemployment is around 7-8 percent. Jobs will include manufacturing, quality control, clinical research and logistics.

Odisha’s Pharma Policy 2025 outlines incentives for pharma parks, MedTech clusters and R&D facilities. If even 10 per cent of the promised investments materialise, Odisha could add value of around Rs 75,000 crore in the next decade and increase the GDP growth rate by 2-3 percentage points annually.

Challenges Ahead

Application Gap: Past meetings have seen less than 30 percent of MoUs materialized. Strict monitoring will be required.

Infrastructure Preparation: Priority should be given to cold chains, testing laboratories and regulatory clearances to suit Gujarat or Telangana.

Lack of Skills: Universities and training institutes must quickly adapt curricula to meet medicine-specific demands.

Global Competition: Odisha needs to offer cost advantage and policy stability to compete with Hyderabad, Pune and Ahmedabad.

The state government and especially the Department of Industries and IPICOL deserve credit for organizing this ambitious summit. Efforts to align policy, infrastructure and investor access laid the foundation for Odisha’s emergence as a pharmaceutical hub.

Odisha Pharma Summit 2025 embodies the vision of Purvodaya, industrial revival in Eastern India. If successful, Odisha will reduce regional imbalance, strengthen India’s healthcare exports and prove that eastern states can support national growth.

However, success will depend on implementation. Odisha needs to move beyond announcements to real factories, real jobs and real GDP growth. As we mentioned above, if even 10 percent of the promises are realized, the impact will be transformative. Otherwise, there is a risk that the summit will be remembered as another expensive spectacle.

Organizing such a mega meeting would cost the state hundreds of millions. Without measurable results, this risks being seen as a wasteful practice. Citizens will rightly question whether public money is being used effectively.

Odisha stands at a crossroads. The choice is between becoming a powerhouse in the pharmaceutical industry or letting the opportunity pass by. The people of Odisha deserve more than promises; they deserve fulfillment.

Charudutta Panigrahi is a public policy expert and technocrat. He can be reached at charudutta403@gmail.com.